A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer
2010 · British Journal of Cancer · 130 citations
https://doi.org/10.1038/sj.bjc.6605650
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
215
Papers
9.8K
Citations
54
h-index
120
i10-index
David J. Chaplin is an academic researcher. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Angiogenesis and VEGF in Cancer & Synthesis and biological activity. The author has an h-index of 54, co-authored 183 publications.
https://doi.org/10.1038/sj.bjc.6605650
https://doi.org/10.1054/bjoc.2000.1361
Click to start Chat